Nasal natural killer (NK)/T-cell lymphoma: Clinical, histological, virological, and genetic features

International Journal of Clinical Oncology

Volumn 14, Issue 3, 2009, Pages 181-190

  Harabuchi, Yasuaki ^a   Takahara, Miki ^a   Kishibe, Kan ^a   Moriai, Shigetaka ^a   Nagato, Toshihiro ^a   Ishii, Hideyuki ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

T Cell; CD56; Epstein Barr virus (EBV); IL 10; IL 9; Immunotherapy; Interferon inducible protein 10 (IP 10); Nasal natural killer (NK) T cell lymphoma; Serum EBV copy number; Superficial temporal arterial infusion chemotherapy

Indexed keywords

CARBOPLATIN; CD2 ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; DEXAMETHASONE; ETOPOSIDE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IFOSFAMIDE; INTERLEUKIN 10; INTERLEUKIN 9; PEPLEOMYCIN; PREDNISOLONE; T LYMPHOCYTE RECEPTOR; VIRUS DNA; CHEMOKINE; CYTOKINE;

CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL FEATURE; CYTOKINE PRODUCTION; EPSTEIN BARR VIRUS; GENE MUTATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; NASAL NATURAL KILLER T CELL LYMPHOMA; NK T CELL LYMPHOMA; NOSE CANCER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SERODIAGNOSIS; TUMOR BIOPSY; TUMOR SUPPRESSOR GENE; BIOSYNTHESIS; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MUTATION; NATURAL KILLER CELL; NOSE TUMOR; PATHOLOGY; PROGNOSIS; T CELL LYMPHOMA;

CHEMOKINES; CYTOKINES; HERPESVIRUS 4, HUMAN; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MUTATION; NOSE NEOPLASMS; PROGNOSIS;

EID: 70349576560     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-009-0882-7     Document Type: Review

References (65)

1. Y. Harabuchi N. Yamanaka A. Kataura, et al. 1990 Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma Lancet 335 128 130 1967431 10.1016/0140-6736(90)90002-M 1:STN:280:DyaK3c7htlKhuw%3D%3D (Pubitemid 20032725)
2. K. Aozasa M. Ohsawa K. Tajima, et al. 1989 Nation-wide study of lethal mid-line granuloma in Japan: frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions Int J Cancer 44 63 66 2744899 10.1002/ijc.2910440112 1:STN:280:DyaL1MzgslKgug%3D%3D
3. Y. Harabuchi S. Imai J. Wakashima, et al. 1996 Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies Cancer 77 2137 2149 8640683 10.1002/(SICI)1097-0142(19960515) 77:10<2137::AID-CNCR27>3.0.CO;2-V 1:STN:280:DyaK283gs1Sgtw%3D%3D (Pubitemid 26142062)
4. J. Lee C. Suh Y.H. Park, et al. 2006 Extranodal natural killer Tcell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study J Clin Oncol 24 612 618 16380410 10.1200/JCO.2005.04.1384 (Pubitemid 46630424)
5. E.S. Jaffe J.K. Chan I.J. Su, et al. 1996 Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology Am J Surg Pathol 20 103 111 8540601 10.1097/00000478-199601000-00012 1:STN:280:DyaK287jtVahug%3D%3D
6. A. Altemani A.C. Barbosa M. Kulka, et al. 2002 Characteristics of nasal T/NK-cell lymphoma among Brazilians Neoplasma 49 55 60 12044062 1:STN:280:DC%2BD38zgtlSrsw%3D%3D
7. K. Gaal N.C. Sun A.M. Hernandez, et al. 2000 Sinonasal NK/T-cell lymphomas in the United States Am J Surg Pathol 24 1511 1517 11075852 10.1097/00000478-200011000-00006 1:STN:280:DC%2BD3M%2FjtlGktw%3D%3D (Pubitemid 30834430)
8. R.W. Vidal K. Devaney A. Ferlito, et al. 1999 Sinonasal malignant lymphomas: a distinct clinicopathological category Ann Otol Rhinol Laryngol 108 411 419 10214792 1:STN:280:DyaK1M3ivFKjtw%3D%3D
9. P. Kanavaros M.C. Lescs J. Briere, et al. 1993 Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus Blood 81 2688 2695 8387835 1:STN:280:DyaK3s3lslKqsg%3D%3D
10. N. Yamanaka Y. Harabuchi S. Sambe, et al. 1985 Non-Hodgkin's lymphoma of Waldeyer's ring and nasal cavity. Clinical and immunologic aspects Cancer 56 768 776 4016670 10.1002/1097-0142(19850815)56:4<768::AID-CNCR2820560412>3.0. CO;2-W 1:STN:280:DyaL2M3lsVaksg%3D%3D (Pubitemid 15228267)
11. N.L. Harris E.S. Jaffe H. Stein, et al. 1994 A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 84 1361 1392 8068936 1:STN:280:DyaK2czkvVSmtQ%3D%3D (Pubitemid 24273002)
12. B.S. Eichel E.G. Harrison Jr K.D. Devine, et al. 1966 Primary lymphoma of the nose including a relationship to lethal midline granuloma Am J Surg 112 597 605 5915307 10.1016/0002-9610(66)90328-X 1:STN:280:DyaF2s%2FgvFWqtg%3D%3D
13. J.F. Emile M.L. Boulland C. Haioun, et al. 1996 CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas Blood 87 1466 1473 8608237 1:CAS:528:DyaK28XhtVGnurg%3D
14. H. Nagata A. Konno N. Kimura, et al. 2001 Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus Blood 97 708 713 11157488 10.1182/blood.V97.3.708 1:CAS:528:DC%2BD3MXhtVSjsb0%3D (Pubitemid 32113404)
15. M.C. Kinney 1999 The role of morphologic features, phenotype, genotype, and anatomic site in defining extranodal T-cell or NKcell neoplasms Am J Clin Pathol 111 Suppl1 S104 118 9894475 1:STN:280:DyaK1M7htFyntA%3D%3D
16. R. Suzuki K. Takeuchi K. Ohshima, et al. 2008 Extranodal NK/T-cell lymphoma: diagnosis and treatment cues Hematol Oncol 26 66 72 18283711 10.1002/hon.847 (Pubitemid 351951334)
17. J. Minarovits L.F. Hu S. Imai, et al. 1994 Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas J Gen Virol 75 77 84 8113742 10.1099/0022-1317-75-1-77 1:CAS:528:DyaK2cXhsFGrs7c%3D
18. P. McBride 1897 Photographs of a case of rapid destruction of the nose and face Laryngol 12 64 66
19. E.J. Kraus 1929 Uber ein eigenartiges Granulom aer Nasen-, Rachen- und Mundhohle Verh Dtsch Ges Pathol 24 43
20. H.L. Williams 1949 Lethal granulomatous ulceration, involving midline facial tissues Ann Otol Rhinol Laryngol 58 1013 1055 15410016 1:STN:280:DyaG3c%2FhvFKnug%3D%3D
21. L. Michaels M. Gregory 1977 Pathology of nonhealing (midline) granuloma J Clin Pathol 30 317 327 323295 10.1136/jcp.30.4.317 1:STN:280: DyaE2s7msFOqsQ%3D%3D
22. Y. Ishii N. Yamanaka K. Ogawa, et al. 1982 Nasal T-cell lymphoma as a type of so-called "lethal midline granuloma." Cancer 50 2336 2344 6754065 10.1002/1097-0142(19821201)50:11<2336::AID-CNCR2820501120>3.0. CO;2-C 1:STN:280:DyaL3s%2FltVGjtg%3D%3D (Pubitemid 13244170)
23. C.S. Ng J.K. Chan S.T. Lo 1987 Expression of natural killer cell markers in non-Hodgkin's lymphomas Hum Pathol 18 1257 1262 3500108 10.1016/S0046- 8177(87)80410-0 1:STN:280:DyaL1c%2Fls12ntA%3D%3D
24. F.C. Ho G. Srivastava S.L. Loke, et al. 1990 Presence of Epstein-Barr virus DNA in nasal lymphomas of B and ";T" cell type Hematol Oncol 8 271 281 1979042 10.1002/hon.2900080505 1:STN:280:DyaK3M%2FmsFGksQ%3D%3D
25. L.J. Medeiros E.S. Jaffe Y.Y. Chen, et al. 1992 Localization of Epstein-Barr viral genomes in angiocentric immunoproliferative lesions Am J Surg Pathol 16 439 447 1318000 1:STN:280:DyaK383os1CjtQ%3D%3D
26. L.M. Weiss M.J. Gaffey Y.Y. Chen, et al. 1992 Frequency of Epstein-Barr viral DNA in "Western" sinonasal and Waldeyer's ring non-Hodgkin's lymphomas Am J Surg Pathol 16 156 162 1310241 1:STN:280:DyaK387isFGruw%3D%3D
27. S. Hirakawa M. Kuyama S. Takahashi, et al. 1999 Nasal and nasal-type natural killer/T-cell lymphoma J Am Acad Dermatol 40 268 272 10025761 10.1016/S0190-9622(99)70204-5 1:STN:280:DyaK1M7kvVKhug%3D%3D (Pubitemid 29072811)
28. X. Wu P. Li J. Zhao, et al. 2008 A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type Clin Oncol (R Coll Radiol) 20 619 625 1:STN:280:DC%2BD1cngtlSnsw%3D%3D
29. M. Takahara K. Kishibe N. Bandoh, et al. 2004 P53, N- and KRas, and beta-catenin gene mutations and prognostic factors in nasal NK/T-cell lymphoma from Hokkaido, Japan Hum Pathol 35 86 95 14745729 10.1016/j.humpath.2003.08.025 1:CAS:528:DC%2BD2cXntVKmug%3D%3D (Pubitemid 38133927)
30. K. Oshimi K. Kawa S. Nakamura, et al. 2005 NK-cell neoplasms in Japan Hematology 10 237 245 16019472 10.1080/10245330400026162 (Pubitemid 41801140)
31. N. Takahashi I. Miura A. Chubachi, et al. 2001 A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma Int J Hematol 74 303 308 11721967 10.1007/BF02982065 1:STN:280:DC%2BD3Mnns1WltA%3D%3D
32. Y. Harabuchi A. Kataura K. Imai 1996 Circulating intercellular adhesion molecule-1 and its cellular expression in head and neck non-Hodgkin's lymphomas, including lethal midline granuloma Ann Otol Rhinol Laryngol 105 634 642 8712635 1:STN:280:DyaK28zjt1agsg%3D%3D
33. M. Ohsawa H. Nakatsuka H. Kanno, et al. 1999 Immunophenotypic and genotypic characterization of nasal lymphoma with polymorphic reticulosis morphology Int J Cancer 81 865 870 10362131 10.1002/(SICI)1097-0215(19990611)81: 6<865::AID-IJC5>3.0.CO;2-S 1:STN:280:DyaK1M3ovV2ktQ%3D%3D (Pubitemid 29249969)
34. P. Gaulard T. Henni J.P. Marolleau, et al. 1988 Lethal midline granuloma (polymorphic reticulosis) and lymphomatoid granulomatosis. Evidence for a monoclonal T-cell lymphoproliferative disorder Cancer 62 705 710 3260812 10.1002/1097-0142(19880815)62:4<705::AID-CNCR2820620410>3.0.CO;2-Z 1:STN:280:DyaL1c3ot1aqsQ%3D%3D (Pubitemid 18186094)
35. T.Y. Yoon H.T. Lee S.H. Chang 1999 Nasal-type T/natural killer cell angiocentric lymphoma, Epstein-Barr virus-associated, and showing clonal T-cell receptor gamma gene rearrangement Br J Dermatol 140 505 508 10233275 10.1046/j.1365-2133.1999.02718.x 1:STN:280:DyaK1M3ltVSjtg%3D%3D (Pubitemid 29182886)
36. A.K. Chiang Q. Tao G. Srivastava, et al. 1996 Nasal NK- and Tcell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease Int J Cancer 68 285 290 8903467 10.1002/(SICI)1097-0215(19961104)68:3<285::AID-IJC3>3.0.CO;2-Y 1:STN:280:DyaK2s%2FmtVCgsA%3D%3D (Pubitemid 26384128)
37. J.E. Kim Y.A. Kim Y.K. Jeon, et al. 2003 Comparative analysis of NK/T-cell lymphoma and peripheral T-cell lymphoma in Korea: clinicopathological correlations and analysis of EBV strain type and 30-bp deletion variant LMP1 Pathol Int 53 735 743 14629296 1:CAS:528:DC%2BD2cXht1amug%3D%3D
38. M. Nagamine M. Takahara K. Kishibe, et al. 2007 Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK/T-cell lymphoma Virus Genes 34 47 54 16917737 10.1007/s11262-006-0008-5 1:CAS:528:DC%2BD2sXjtFKiug%3D%3D (Pubitemid 46071655)
39. M. Nagamine K. Kishibe M. Takahara, et al. 2007 Selected amino acid change encoding Epstein-Barr virus-specific T cell epitope of the LMP2A gene in Japanese nasal NK/T cell lymphoma patients Intervirology 50 319 322 17657160 10.1159/000106462 1:CAS:528:DC%2BD2sXht1agsLfM (Pubitemid 350014914)
40. H.F. Tien I.J. Su J.L. Tang, et al. 1997 Clonal chromosomal abnormalities as direct evidence for clonality in nasal T/natural killer cell lymphomas Br J Haematol 97 621 625 9207410 10.1046/j.1365-2141.1997.752711.x 1:STN:280:DyaK2szltFSgtg%3D%3D
41. K.F. Wong J.K. Chan Y.L. Kwong 1997 Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma/leukaemia Br J Haematol 98 922 926 9326190 10.1046/j.1365-2141.1997.3223139.x 1:CAS:528:DyaK2sXmslyhsbs%3D
42. L.L. Siu V. Chan J.K. Chan, et al. 2000 Consistent patterns of allelic loss in natural killer cell lymphoma Am J Pathol 157 1803 1809 11106552 1:STN:280:DC%2BD3M%2FntFGmsw%3D%3D
43. H.S. Sun I.J. Su Y.C. Lin, et al. 2003 A 2.6 Mb interval on chromosome 6q25.2-q25.3 is commonly deleted in human nasal natural killer/T-cell lymphoma Br J Haematol 122 590 599 12899714 10.1046/j.1365-2141.2003.04419.x 1:CAS:528:DC%2BD3sXnsVCguro%3D (Pubitemid 36995213)
44. T. Takakuwa Z. Dong S. Nakatsuka, et al. 2002 Frequent mutations of Fas gene in nasal NK/T cell lymphoma Oncogene 21 4702 4705 12096347 10.1038/sj.onc.1205571 1:CAS:528:DC%2BD38XltVShur0%3D (Pubitemid 34833148)
45. L. Shen A.C. Liang L. Lu, et al. 2002 Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma Am J Pathol 161 2123 2131 12466128 1:CAS:528: DC%2BD38XpslemurY%3D
46. T. Li T. Hongyo M. Syaifudin, et al. 2000 Mutations of the p53 gene in nasal NK/T-cell lymphoma Lab Invest 80 493 499 10780666 1:CAS:528: DC%2BD3cXjtl2ksrk%3D
47. Y. Hoshida T. Hongyo X. Jia, et al. 2003 Analysis of p53, K-ras, c-kit, and beta-catenin gene mutations in sinonasal NK/T cell lymphoma in northeast district of China Cancer Sci 94 297 301 12824925 10.1111/j.1349-7006.2003. tb01436.x 1:CAS:528:DC%2BD3sXktVCqsLg%3D (Pubitemid 36575898)
48. L. Quintanilla-Martinez M. Kremer G. Keller, et al. 2001 p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease Am J Pathol 159 2095 2105 11733360 1:CAS:528:DC%2BD38Xhslaqsg%3D%3D
49. T. Hongyo Y. Hoshida S. Nakatsuka, et al. 2005 p53, K-ras, c-kit and beta-catenin gene mutations in sinonasal NK/T-cell lymphoma in Korea and Japan Oncol Rep 13 265 271 15643509 1:CAS:528:DC%2BD2MXhsVGrtbk%3D
50. T. Nagato H. Kobayashi K. Kishibe, et al. 2005 Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients Clin Cancer Res 11 8250 8257 16322282 10.1158/1078-0432.CCR-05-1426 1:CAS:528:DC%2BD2MXht1KjsrjM (Pubitemid 41746934)
51. L. Yang K. Aozasa K. Oshimi, et al. 2004 Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction Cancer Res 64 5332 5337 15289339 10.1158/0008-5472.CAN-04-0733 1:CAS:528:DC%2BD2cXmtF2murs%3D (Pubitemid 39006553)
52. M. Takahara L.L. Kis N. Nagy, et al. 2006 Concomitant increase of LMP1 and CD25 (IL-2-receptor alpha) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3 Int J Cancer 119 2775 2783 17013900 10.1002/ijc.22139 1:CAS:528:DC%2BD28Xht1yqt7vJ (Pubitemid 44846228)
53. R. Liang 2000 Diagnosis and management of primary nasal lymphoma of T-cell or NK-cell origin Clin Lymphoma 1 33 37 11707809 10.3816/CLM.2000.n.002 1:STN:280:DC%2BD3MnlsVCqtA%3D%3D
54. K.I. Lei L.Y. Chan W.Y. Chan, et al. 2000 Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies Br J Haematol 111 239 246 11091207 10.1046/j.1365-2141.2000.02344.x 1:STN:280:DC%2BD3M%2FltFaitQ%3D%3D (Pubitemid 30832457)
55. H. Ishii T. Ogino C. Berger, et al. 2007 Clinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for nasal NK/Tcell lymphoma J Med Virol 79 562 572 17385697 10.1002/jmv.20853 1:CAS:528:DC%2BD2sXkvFyktLw%3D (Pubitemid 46564355)
56. W.Y. Au A. Pang C. Choy, et al. 2004 Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients Blood 104 243 249 15031209 10.1182/blood-2003-12-4197 1:CAS:528:DC%2BD2cXlslWgsb0%3D (Pubitemid 38879864)
57. K. Isobe T. Uno J. Tamaru, et al. 2006 Extranodal natural killer/ T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters Cancer 106 609 615 16369986 10.1002/cncr.21656 (Pubitemid 43157624)
58. M. Yamaguchi S. Ogawa Y. Nomoto 2001 Treatment outcome of nasal NK-cell lymphoma: a case report of 12 consecutively-diagnosed cases and a review of the literature J Clin Exp Hematopathol 41 93 99
59. M. Yamaguchi K. Kita H. Miwa, et al. 1995 Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells Cancer 76 2351 2356 8635042 10.1002/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1 1:STN:280:DyaK283itlaqsw%3D%3D
60. S. Imashuku 2000 Advances in the management of hemophagocytic lymphohistiocytosis Int J Hematol 72 1 11 10979202 1:STN:280: DC%2BD3cvpt1GitQ%3D%3D
61. M. Yamaguchi R. Suzuki Y.L. Kwong, et al. 2008 Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia Cancer Sci 99 1016 1020 18294294 10.1111/j.1349-7006.2008.00768.x 1:CAS:528:DC%2BD1cXlslCrt7w%3D (Pubitemid 351997606)
62. K. Takenaka K. Shinagawa Y. Maeda, et al. 2001 High-dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal and nasal-type CD56+ natural killer cell lymphomas Leuk Lymphoma 42 1297 1303 11911411 10.1080/10428190127500 1:CAS:528:DC%2BD38XitVSnsbw%3D (Pubitemid 34082917)
63. N. Murashige M. Kami Y. Kishi, et al. 2005 Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms Br J Haematol 130 561 567 16098071 10.1111/j.1365-2141.2005.05651.x (Pubitemid 43899760)
64. R. Suzuki J. Suzumiya S. Nakamura, et al. 2006 Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms Bone Marrow Transplant 37 425 431 16400344 10.1038/sj.bmt.1705244 1:STN:280:DC%2BD28%2FnvVejtA%3D%3D (Pubitemid 43250478)
65. H. Kobayashi T. Nagato M. Takahara, et al. 2008 Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells Cancer Res 68 901 908 18245493 10.1158/0008-5472.CAN-07-3212 1:CAS:528:DC%2BD1cXhtlygtb8%3D (Pubitemid 351206769)